Search research articles
Contact Us
Filters
Showing results (111-120 of 145) with videos related to
Page
of 15
Sort By:
Neoplasia (New York, N.Y.)
|
August 10, 2000
Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis
J G Einspahr, D S Alberts, J A Warneke, et al.
Human Pathology
|
May 1, 1985
The immunoarchitecture of cutaneous pseudolymphoma
D P Wirt, T M Grogan, C S Jolley, et al.
American Journal of Clinical Pathology
|
October 1, 1996
Rapid automated combined in situ hybridization and immunohistochemistry for sensitive detection of cytomegalovirus in paraffin-embedded tissue biopsies
L M Rimsza, E E Vela, Y M Frutiger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2001
Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study
P M Fracasso, M F Brady, D H Moore, et al.
Blood
|
July 15, 1990
Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19)
B Van Camp, B G Durie, C Spier, et al.
Blood
|
December 1, 1992
Long-term engraftment of fresh human myeloma cells in SCID mice
F J Feo-Zuppardi, C W Taylor, K Iwato, et al.
Cancer Treatment Reports
|
April 1, 1982
Changing patterns of Hodgkin's disease at autopsy: a 25-year experience at the National Cancer Institute, 1953--1978
T M Grogan, C W Berard, S C Steinhorn, et al.
Cancer Research
|
June 15, 1997
Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein
H S Chan, Y Lu, T M Grogan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1989
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy
W S Dalton, T M Grogan, P S Meltzer, et al.
Blood
|
October 1, 1987
Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features
T M Grogan, B G Durie, C Lomen, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 145) with videos related to
Sort By:
Page
of 15
Neoplasia (New York, N.Y.)
|
August 10, 2000
Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis
J G Einspahr, D S Alberts, J A Warneke, et al.
Human Pathology
|
May 1, 1985
The immunoarchitecture of cutaneous pseudolymphoma
D P Wirt, T M Grogan, C S Jolley, et al.
American Journal of Clinical Pathology
|
October 1, 1996
Rapid automated combined in situ hybridization and immunohistochemistry for sensitive detection of cytomegalovirus in paraffin-embedded tissue biopsies
L M Rimsza, E E Vela, Y M Frutiger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2001
Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study
P M Fracasso, M F Brady, D H Moore, et al.
Blood
|
July 15, 1990
Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19)
B Van Camp, B G Durie, C Spier, et al.
Blood
|
December 1, 1992
Long-term engraftment of fresh human myeloma cells in SCID mice
F J Feo-Zuppardi, C W Taylor, K Iwato, et al.
Cancer Treatment Reports
|
April 1, 1982
Changing patterns of Hodgkin's disease at autopsy: a 25-year experience at the National Cancer Institute, 1953--1978
T M Grogan, C W Berard, S C Steinhorn, et al.
Cancer Research
|
June 15, 1997
Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein
H S Chan, Y Lu, T M Grogan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1989
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy
W S Dalton, T M Grogan, P S Meltzer, et al.
Blood
|
October 1, 1987
Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features
T M Grogan, B G Durie, C Lomen, et al.
Page
of 15